 |
|
|
|
|
|
|
|
|
If you are a member of the media and would like to speak to someone in Corporate Communications, please call our media line at (+1) 919 316 6316. Inquiries from journalists only please.
Quick Facts:
 |
Talecris is headquartered in the biotech hub of Research Triangle Park, NC, USA. Additional regional headquarters are located in Toronto, Canada, and Frankfurt, Germany.
|
|
Talecris employees, more than 4,000 worldwide, include outstanding scientists and business professionals recognized by peers, partners, patients, and professionals as passionate and committed to their work.
|
|
Our primary manufacturing facility is in Clayton, NC, USA; additional fractionation capacity and contract manufacturing is provided by our facility in Melville, NY.
|
|
Our Clayton, NC, facility was recently honored as an Industry Week 2007 Best Plants Finalist in recognition of its excellent performance metrics.
|
|
Talecris discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, and hemostasis.
|
|
Talecris Plasma Resources, Inc. (TPR), a wholly owned subsidiary of Talecris Biotherapeutics, is a network of plasma collection centers that provides the source material for the production of Talecris’ critical care protein therapies.
|
|
Talecris' revenues exceeded approximately $1.2 billion in 2007.
|
|
Between its launch in 2005 through the end of 2007, Talecris invested in excess of $550 million to support the growth of the business.
|
|
Talecris was named a "Fast 50" award winner, recognizing it as one of Research Triangle Park's fastest-growing privately held companies. The award honors privately owned businesses and their contribution to the growth and success of the entire community. |
|
|
|
|
|
|
|
|
